Taken together, our observations suggest that these two flavonoids tested, most prominently apigenin, suppress PD-L1 expression on melanoma cells, thus unleashing PD-L1/PD-1 checkpoint-mediated immune suppression and therefore eliciting more efficient T cell killings. This evidence concerns the gene CD274 and melanoma.